Gliptin, a dipeptidyl peptidase-4 inhibitor used to treat diabetes mellitus, can cause cough as a side effect, which may be attributed to the persistent cough of COVID-19 [40]. This evidence concerns the gene DPP4 and diabetes mellitus.